Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds. Medscape Medical News
Author: Medscape
Infantile Hemangiomas: When Is a PHACE Workup Warranted?
Most congenital hemangiomas on the skin are managed with standard therapies, but an expert specified lesions that are at risk for systemic complications to provide guidance for rapid intervention. Medscape Medical News
Zanubrutinib May Benefit Patients With IgG4-Related Disease
Zanubrutinib monotherapy may help shrink inflamed glands, ease symptoms, and is generally well tolerated in patients with immunoglobulin G4-related head and neck disease, a phase 2 study shows. Medscape Medical News
EU Panel Backs First Refillable Eye Implant for AMD
Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills. Medscape Medical News
US FDA Approves Outlook Therapeutics’ Eye Disease Drug
Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for a type of eye disease that can cause vision loss. Reuters Health Information
Gene Therapy Delivers Sustained Retinal Protection
People with age-related macular degeneration maintain vision and cut their need for supplemental injections by 90% 5 years after receiving gene therapy. Medscape Medical News
Faricimab Reduces Shots, Improves Vision for Retinal Disease
In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs. Medscape Medical News
Delays Harmless for Most Macular Degeneration Patients
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss. Medscape Medical News
Faricimab May Aid Hard-to-Treat Macular Degeneration Cases
Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration. Medscape Medical News
Home Eye Scans Best Suited for High-Cost Retina Meds
Home-based optical tomography may only be cost-effective for patients on more expensive treatments. Medscape Medical News
Pott’s Puffy Tumor in Teen Leads to Bilateral Blindness
A teen with Pott’s puffy tumor develops irreversible bilateral blindness after delayed diagnosis and intracranial complications, highlighting the importance of its early recognition. Medscape Global
Nonvalved Drainage Device Benefits Kids With Glaucoma
In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years. Medscape Medical News
ASRS 2026
Read clinically focused news coverage of key developments from ASRS 2026. Medscape Internal Medicine
Closing Your Practice? Don’t Overlook These Legal Issues
Healthcare attorney Ericka Adler outlines what physicians need to know about patient notification, medical records, malpractice coverage, and practice closure. Medscape Business of Medicine
SMC Accepts First Drug to Improve Survival in Uveal Melanoma
Scotland approves tebentafusp for metastatic uveal melanoma, a rare eye cancer with a median survival of around 12 months. Medscape News UK
Study Probes Absolute Risk for ION With GLP-1 Agents
In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, claims data show. Medscape Medical News
Elevated Interferon Alfa May Reveal Sjögren Disease Subtype
Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings. Medscape Medical News
High Eye Pressure? Vitamin B3 May Shield Against Glaucoma
Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows. Medscape Medical News
Delayed TED Underrecognized Following MS Treatment
Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory therapy including alemtuzumab. Medscape Medical News
Uveitis Patterns Vary in Relation to Spondyloarthritis Type
Patients with peripheral forms of spondyloarthritis show a higher prevalence of different uveitis patterns than those with axial forms. Medscape Medical News